¿La quimioterapia neoadyuvante proporciona algún beneficio para la desescalada quirúrgica en el cáncer de mama HER2(–) luminal B?

Aysegul Aktas ¹, Meryem Gunay-Gurleyik ¹, Fugen Aker ², Yasar Kaan-Akgok ², Elif Atag ³

¹ Department of General Surgery, Haydarpasa Numune Training and Research Hospital, University of Health Sciences Turkey, Istanbul, Turkey; ² Department of Pathology, Haydarpasa Numune Training and Research Hospital, University of Health Sciences Turkey, Istanbul, Turkey; ³ Department of Medical Oncology, Haydarpasa Numune Training and Research Hospital. University of Health Sciences Turkey, Istanbul, Turkey